This compound is an ethyl ester derivative of an imidazo-benzodiazepine, specifically identified as a benzodiazepine impurity reference standard. It is used in pharmaceutical manufacturing and quality control to ensure the purity of benzodiazepine drug substances.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 59469-49-7
8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid
pharmaceutical intermediate
7-Bromo-5-(6-methylpyridin-2-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one
benzodiazepine impurity reference standard
11-?Chloro-?N-?methyl-?2-?phenyl-?3-?oxa-?4,?7-?diazatricyclo[6.4.0.?0{2,?4}?]?dodeca-?1(12)?,?6,?8,?10-?tetraen-?6-?amine
benzodiazepine impurity reference standard
REDUCED MIDAZOLAM
benzodiazepine impurity reference standard
Midazolam 6H-
active pharmaceutical ingredient
Somatostatin, tyr(11)-
active pharmaceutical ingredient
Vyndamax
active pharmaceutical ingredient
MEGESTROL ACETATE
active pharmaceutical ingredient
ethyl 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
OYQYAYKJGZHIMD-UHFFFAOYSA-N
CCOC(=O)C1=C2CN=C(C3=C(N2C(=N1)C)C=CC(=C3)Cl)C4=CC=CC=C4F
—